Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results
31 juil. 2014 16h30 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline Review
01 mai 2014 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences
30 avr. 2014 08h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will host a fireside chat at the Deutsche Bank Securities 39th...
Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C
07 avr. 2014 07h00 HE
|
Idenix Pharmaceuticals
Idenix Reports Positive Proof-of-Concept Data for Lead Nucleotide Prodrug, IDX21437
Idenix on Track to Initiate All-Oral Pan-Genotypic Phase II Combination Clinical Study of IDX21437 and...
Idenix Announces Nucleotide Prodrug (IDX21437) and NS5A Inhibitor (Samatasvir) Poster Presentations at 49th Annual Meeting of the European Association for the Study of the Liver
24 mars 2014 08h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case
24 mars 2014 07h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
14 mars 2014 07h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 14, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial Results
27 févr. 2014 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
26 févr. 2014 08h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present at the Cowen & Company 34th Annual Health Care...
Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference
07 févr. 2014 08h30 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat discussion at the 2014 Leerink...